CIK 0001815442 · Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812992166
- Phone
- 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-03 | Ridloff Elena Director | Sale 10b5-1 | −7,200 | $45.50 | $328K | 4,800 |
| 2025-06-03 | Ridloff Elena Director | Sale 10b5-1 | −4,800 | $47.00 | $226K | 0 |
| 2025-06-03 | Ridloff Elena Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,000 | 0 | ||
| 2025-06-03 | Mainolfi Nello Chief Executive Officer | Option exercise 10b5-1 | +30,000 | $2.08 | $62K | 690,482 |
| 2025-06-03 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −30,000 | $49.00 | $1.5M | 660,482 |
| 2025-06-03 | Mainolfi Nello Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 465,559 | ||
| 2025-06-03 | Albers Jeffrey W. Director | Option exercise 10b5-1 | +6,349 | $10.34 | $66K | 6,349 |
| 2025-06-03 | Albers Jeffrey W. Director | Sale 10b5-1 | −6,349 | $49.00 | $311K | 0 |
| 2025-06-03 | Albers Jeffrey W. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,349 | 5,000 | ||
| 2025-05-23 | Chadwick Jeremy G Chief Operating Officer | Sale | −2,575 | $29.30 | $75K | 66,420 |
| 2025-04-08 | Goodman Noah Chief Business Officer | Grant or award | +50,000 | 50,081.44 | ||
| 2025-04-08 | Goodman Noah Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-03-31 | Jacobs Bruce N. Chief Financial Officer | Option exercise | +25,000 | $2.08 | $52K | 226,886 |
| 2025-03-31 | Jacobs Bruce N. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −25,000 | 69,899 | ||
| 2025-03-03 | Chiniara Ellen Chief Legal Officer | Grant or award | +27,500 | 82,326 | ||
| 2025-03-03 | Chiniara Ellen Chief Legal Officer | Sale | −1,833 | $30.33 | $56K | 80,493 |
| 2025-03-03 | Chiniara Ellen Chief Legal Officer | Sale | −408 | $31.00 | $13K | 80,085 |
| 2025-03-03 | Chiniara Ellen Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-03-03 | Chadwick Jeremy G Chief Operating Officer | Grant or award | +25,000 | 69,183 | ||
| 2025-03-03 | Chadwick Jeremy G Chief Operating Officer | Sale | −1,131 | $30.33 | $34K | 68,052 |
Page 23 of 25 · 493 trades